We observed that relative to the pan-HDACi 1, the class I selective HDACi 2 and 3a more effectively inhibited the proliferation of HCC cell lines in the WST-1 assay regardless of their p53 expression status. The gene discussed is TP53; the disease is hepatocellular carcinoma.